France Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
France Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the France Cell and Gene Therapy Manufacturing QC Market was valued at USD 51.13 Million in 2024 and is projected to reach USD 127.21 Million by 2028, expanding at a CAGR of 25.7% during the forecast period. This market growth is largely driven by various industries such as pharmaceuticals, healthcare, and biotechnology, with applications centered around disease treatment. Technological advances in gene editing tools and increasing numbers of gene therapy candidates entering clinical stages are driving this robust growth. Furthermore, the green production of cell therapies presents a significant opportunity, with France's biotechnological sector making strides towards more sustainable manufacturing practices. Given this panorama of growth and innovation, France is well-positioned to become a frontrunner in the global cell and gene therapy manufacturing quality control market in the coming years.
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market Highlights
- In 2024, Cell Therapy accounted for the highest share of the Therapy Type market size.
- During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative Therapy Type segment.
- France accounted for 2.29% of the global cell and gene therapy manufacturing qc market size in 2024.
- By 2028, United States is expected to remain the top global market in terms of size.
- Within Europe, Germany is forecasted to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
- France will be the fastest-growing market in Europe, projected to achieve USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 51.13 Million |
| Market Size In 2028 | USD 127.21 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 25.7% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
France Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
France Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
France Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
